FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

MS and Life Expectancy




























A 7-year difference in life expectancy between the MS population and the general population. Similar results were observed in study 1 (Marrie R. A. et al) and study 2 (Lunde H. M. B. et al).

According to the national MS society, MS is not a fatal illness. There are, however, rare cases of rapid disease progression that can be fatal.

The life expectancy of someone living with multiple sclerosis is estimated to be about seven years shorter than that of the general population. With the continuous advancements in medicine and improvements in healthcare and lifestyle, this discrepancy in life expectancy has reduced over time. In addition, both the MS population and the general population has seen a striking increase in longevity in the last decades.

In a Canadian study to investigate the association between concurrent diseases and survival, a group of over 5000 MS patients was compared to another group of about 28000 people from the general population.

The research team observed a shorter life expectancy in the MS group. The median survival was 76 and 83 years, for the MS group and the general population, respectively. In both groups, concurrent diseases were found to have a significant impact on life expectancy. The magnitude of the observed impact was not higher in the MS group.

A similar study was conducted in Norway to investigate survival and cause of death in a sample of patients with MS patients compared to the general population. Over a period of 60 years, people diagnosed with MS were enrolled in the study. A median survival of 75 years was observed in the MS sample against 82 years in the general population—also a difference of 7 years, similar to the results of the previous study described above.


In additional to presenting evidence of the difference in life expectancy between both populations, some studies conducted interim analyses at different time points over time. It has been shown that the difference in life expectancy between both populations tends to decrease with time. This means that the difference in life expectancy used to be higher a few decades ago compared to today.

Story Source: The above story is based on materials provided by HEALDOVE
Note: Materials may be edited for content and length


Go to Older News